PCSK9 and prediabetes syndrome: In contrast, other drugs that do not act on PCSK9, such as bempedoic acid, do not worsen fasting glucose or HbA1c in patients with diabetes or prediabetes, or increase the incidence of new-onset diabetes in patients with normoglycemia compared with placebo (25).